WGS
GeneDx Holdings Corp

4,454
Mkt Cap
$4.04B
Volume
628,158.00
52W High
$146.00
52W Low
$55.17
PE Ratio
2,317.25
WGS Fundamentals
Price
$139.73
Prev Close
$138.70
Open
$136.42
50D MA
$125.41
Beta
1.63
Avg. Volume
585,581.00
EPS (Annual)
-$1.94
P/B
13.81
Rev/Employee
$305,450.00
Loading...
Loading...
News
all
press releases
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will unveil research findings during four key sessions at the 2025 National Society...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
GeneDx to Participate in Upcoming Investor Conferences
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Stifel 2025...
Business Wire·4d ago
News Placeholder
GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates
GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +75.00% and +12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
News Placeholder
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third quarter of 2025. GeneDxs accelerated...
Business Wire·11d ago
News Placeholder
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating...
PR Newswire·12d ago
News Placeholder
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of GeneDx Holdings Corp. (NASDAQ: WGS) breached their fiduciary duties to shareholders. If you...
Business Wire·15d ago
News Placeholder
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced data and presentations at the International Consortium on Newborn Sequencing (ICoNS...
Business Wire·17d ago
News Placeholder
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot...
PR Newswire·24d ago
News Placeholder
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Dr. Mimi Lee, MD, PhD, as Chief Precision Medicine Officer. Dr. Lee will spearhead...
Business Wire·25d ago
News Placeholder
InnovAge (INNV) Surges 8.6%: Is This an Indication of Further Gains?
InnovAge (INNV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·25d ago

Latest WGS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.